Tony Chen

Partner
Shanghai/
San Diego
Tel: 86.21.2201.8079 / 1.858.314.1200 (San Diego)
Fax: 86.21.5298.6569 / 1.858.314.1150
Email:
tonychen@jonesday.com
Simplified Chinese Biography
Profile
|
Publications
|
Speaking Engagements
Related Services
Tony has 15 years of experience assisting high-tech and biotech companies with their intellectual property matters in the United States and in China. His practice focuses on patent litigation and portfolio management, technology transfer, and the formation and financing of technology start-ups. Since moving to China in 2004, Tony has represented multinational companies with enforcing their intellectual property rights in civil actions and through criminal sanctions. He also has represented Chinese companies with building and acquiring intellectual property on a worldwide basis. In addition, he counsels the Shanghai government on life science industry and intellectual property matters.
At the start of his career Tony practiced patent law for six years in San Diego and represented a wide range of high-tech and biotech companies in patent litigation, prosecution, and licensing. During this time his life science IP practice included genetic engineering, drug therapeutics, medical devices, chemistry, diagnostics, herbal medicine, and DNA chips.
Tony then became the first in-house patent counsel for Watson Pharmaceuticals, a leading global generic drug and specialty pharmaceutical company. At Watson, he was responsible for intellectual property strategy and litigation relating to the commercialization of generic drugs and proprietary pharmaceutical products. In 2000, Tony founded a biotechnology company in Silicon Valley to develop products for drug discovery with the support of venture capital investors in the U.S., Europe, and Asia. He also studied molecular biology at Vanderbilt University before beginning his legal studies.
Tony's recent representations in China include:
a U.S. retail chain in defending a patent infringement lawsuit in China and invalidating a Chinese patent
an Asian software company in a criminal enforcement against trade secret theft
U.S. biotechnology companies in R&D collaborations and drug development partnerships in China
Chinese biotechnology companies in patent licensing and technology transfer agreements with U.S. biotechnology companies and
Chinese companies in defending patent and trademark infringement lawsuits in federal district courts in the U.S.
Admitted
California and registered to practice before the U.S. Patent and Trademark Office
Education
Harvard University (J.D. 1993); University of Science and Technology of China (B.S. in Cell Biology 1987)
Languages
Chinese, English